The Role of Human Parainfluenza Virus Infections in the Immunopathology of the Respiratory Tract
- 10 March 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Allergy and Asthma Reports
- Vol. 17 (3), 1-10
- https://doi.org/10.1007/s11882-017-0685-2
Abstract
Viral infections are leading causes of both upper and lower airway acute illness in all age groups of healthy persons, and have also been implicated in the acute exacerbations of chronic respiratory disorders like asthma and COPD. Human rhinovirus, respiratory syncytial virus, influenza virus and coronavirus have been considered as the most important respiratory pathogens and relatively little attention has been paid to the role of parainfluenza viruses (hPIVs). Human parainfluenza viruses are single-stranded RNA viruses belonging to the paramyxovirus family that may evoke lower respiratory infections in infants, children and immunocompromised individuals. Among non-immune compromised adults, hPIV infection typically causes mild disease manifested as upper respiratory tract symptoms and is infrequently associated with severe croup or pneumonia. Moreover, hPIV infection may be associated with viral exacerbations of chronic airway diseases, asthma or COPD or chronic rhinosinusitis. In this review, we summarized the basic epidemiology and immunology of hPIVs and addressed the more recent data implicating the role of parainfluenza viruses in the exacerbation of chronic airway disorders.Keywords
Funding Information
- National Science Centre (2011/02/A/NZ5/00341)
This publication has 63 references indexed in Scilit:
- Interaction between the Hemagglutinin-Neuraminidase and Fusion Glycoproteins of Human Parainfluenza Virus Type III Regulates Viral Growth In VivomBio, 2013
- Epidemiology and clinical presentation of the four human parainfluenza virus typesBMC Infectious Diseases, 2013
- Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young childrenVaccine, 2012
- The cDNA-derived Investigational Human Parainfluenza Virus Type 3 Vaccine rcp45 Is Well Tolerated, Infectious, and Immunogenic in Infants and Young ChildrenThe Pediatric Infectious Disease Journal, 2011
- A Recombinant Sialidase Fusion Protein Effectively Inhibits Human Parainfluenza Viral Infection In Vitro and In VivoThe Journal of Infectious Diseases, 2010
- Viral Entry Inhibitors Targeted to the Membrane Site of ActionJournal of Virology, 2010
- CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway EpitheliumPLoS Biology, 2009
- A Shared Interface Mediates Paramyxovirus Interference with Antiviral RNA Helicases MDA5 and LGP2Journal of Virology, 2009
- Select Paramyxoviral V Proteins Inhibit IRF3 Activation by Acting as Alternative Substrates for Inhibitor of κB Kinase ϵ (IKKe)/TBK1Online Journal of Public Health Informatics, 2008
- Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infectionBlood, 2007